Systems pharmacology analysis of oncology drug combinations to evaluate adverse events due to drug-drug interactions

被引：0
|
作者：
Kim, Sarah [1 ]
Lahu, Gezim [2 ]
Lesko, Lawrence J. [1 ]
Trame, Mirjam N. [1 ]
机构：
[1] Univ Florida, Ctr Pharmacometr & Syst Pharmacol, Orlando, FL USA
[2] Takeda Pharmaceut Int GmbH, Zurich, Switzerland
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-68
引用
收藏
页码：S115 / S116
页数：2
相关论文
共 50 条
  • [21] FLUOXETINE - ADVERSE-EFFECTS AND DRUG-DRUG INTERACTIONS
    MESSIHA, FS
    JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1993, 31 (04): : 603 - 630
  • [22] PROBABILITY OF ADVERSE DRUG-DRUG INTERACTIONS IN MULTIPLE PRESCRIPTIONS
    HEDDON, J
    CORBETT, R
    SOUTH AFRICAN JOURNAL OF SCIENCE, 1979, 75 (07) : 320 - 320
  • [23] Data mining for potential adverse drug-drug interactions
    Hammann, Felix
    Drewe, Juergen
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (05) : 665 - 671
  • [24] Drug-Drug Interactions - Induced Adverse Drug Reactions in Hospitalized Patients
    Ponte, M.
    Serra, H.
    Wachs, A.
    DRUG SAFETY, 2012, 35 (10) : 882 - 882
  • [25] Potential drug-drug interactions and adverse drug reactions in dermatological inpatients
    Koch, Lukas
    Kraenke, Birger
    Aberer, Werner
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (11): : 1122 - 1129
  • [26] Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions
    Magro, Lara
    Moretti, Ugo
    Leone, Roberto
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (01) : 83 - 94
  • [27] Drug-drug combinations revisited
    Bjerrum, Ole J.
    Gautam, Yvonne
    Honore, Per H.
    Vana, Vasiliki
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2014, 21 (01): : 8 - 12
  • [28] Analysis of drug-drug interactions: An overview
    Shipman, C
    ANTIVIRAL RESEARCH, 1996, 29 (01) : 41 - 43
  • [29] Drug polypharmacy patterns in geriatric patients receiving chemotherapy: Implications for drug-drug interactions and adverse events.
    Sokol, K
    Krasnow, R
    Knudsen, J
    Cantilena, L
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1087 - 1087
  • [30] MODULATORS FOR ELECTRONIC RISK PREDICTION OF ADVERSE DRUG EVENTS - PATIENT CHARACTERISTICS IN DRUG-DRUG INTERACTIONS AND DOSE ADJUSTMENTS
    Senger, C.
    Seidling, H. M.
    Schmitt, S. P. W.
    Bertsche, T.
    Szymanski, J.
    Schmiedl, S.
    Rottenkolber, M.
    Kaltschmidt, J.
    Drewelow, B.
    Siegmund, W.
    Hippius, M.
    Farker, K.
    Hasford, J.
    Thuermann, P. A.
    Haefeli, W. E.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 43 - 43
12345